108 related articles for article (PubMed ID: 10403133)
21. A rapid and validated HPLC method to quantify sphingosine 1-phosphate in human plasma using solid-phase extraction followed by derivatization with fluorescence detection.
Butter JJ; Koopmans RP; Michel MC
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):65-70. PubMed ID: 16023899
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of free sphingosine in liver by high-performance liquid chromatography.
Merrill AH; Wang E; Mullins RE; Jamison WC; Nimkar S; Liotta DC
Anal Biochem; 1988 Jun; 171(2):373-81. PubMed ID: 3407935
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
Ahn EH; Chang CC; Schroeder JJ
Exp Biol Med (Maywood); 2006 Nov; 231(10):1664-72. PubMed ID: 17060688
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine determination at the picomole level using dimethylaminoazobenzene sulphonyl chloride.
Rosenfelder G; Chang JY; Braun DG
J Chromatogr; 1983 Jan; 272(1):21-7. PubMed ID: 6404916
[TBL] [Abstract][Full Text] [Related]
25. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry.
Sullards MC
Methods Enzymol; 2000; 312():32-45. PubMed ID: 11070861
[TBL] [Abstract][Full Text] [Related]
26. Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders.
Rodriguez-Lafrasse C; Rousson R; Pentchev PG; Louisot P; Vanier MT
Biochim Biophys Acta; 1994 May; 1226(2):138-44. PubMed ID: 8204660
[TBL] [Abstract][Full Text] [Related]
27. Quantification of sphingosine and sphinganine from crude lipid extracts by HPLC electrospray ionization tandem mass spectrometry.
Lieser B; Liebisch G; Drobnik W; Schmitz G
J Lipid Res; 2003 Nov; 44(11):2209-16. PubMed ID: 12897185
[TBL] [Abstract][Full Text] [Related]
28. Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination.
Sánchez BA; Capote FP; Luque de Castro MD
Anal Bioanal Chem; 2011 May; 400(3):757-65. PubMed ID: 21394454
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
30. Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1.
Qiu M; Liu X
Food Addit Contam; 2001 Mar; 18(3):263-9. PubMed ID: 11304035
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis induction by wheat-flour sphingoid bases in DLD-1 human colon cancer cells.
Sugawara T; Kinoshita M; Ohnishi M; Miyazawa T
Biosci Biotechnol Biochem; 2002 Oct; 66(10):2228-31. PubMed ID: 12450138
[TBL] [Abstract][Full Text] [Related]
32. In vivo distribution of free long-chain sphingoid bases in the human stratum corneum by high-performance liquid chromatographic analysis of strippings.
Flamand N; Justine P; Bernaud F; Rougier A; Gaetani Q
J Chromatogr B Biomed Appl; 1994 Jun; 656(1):65-71. PubMed ID: 7952048
[TBL] [Abstract][Full Text] [Related]
33. Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues.
Castegnaro M; Garren L; Gaucher I; Wild CP
Nat Toxins; 1996; 4(6):284-90. PubMed ID: 9029554
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
Ahn EH; Schroeder JJ
Anticancer Res; 2010 Jul; 30(7):2881-4. PubMed ID: 20683027
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS/MS with identical
Mirzaian M; Wisse P; Ferraz MJ; Marques ARA; Gaspar P; Oussoren SV; Kytidou K; Codée JDC; van der Marel G; Overkleeft HS; Aerts JM
Clin Chim Acta; 2017 Mar; 466():178-184. PubMed ID: 28089753
[TBL] [Abstract][Full Text] [Related]
36. Efflux of sphingoid bases by P-glycoprotein in human intestinal Caco-2 cells.
Sugawara T; Kinoshita M; Ohnishi M; Tsuzuki T; Miyazawa T; Nagata J; Hirata T; Saito M
Biosci Biotechnol Biochem; 2004 Dec; 68(12):2541-6. PubMed ID: 15618625
[TBL] [Abstract][Full Text] [Related]
37. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.
Wang E; Riley RT; Meredith FI; Merrill AH
J Nutr; 1999 Jan; 129(1):214-20. PubMed ID: 9915902
[TBL] [Abstract][Full Text] [Related]
38. Fumonisin-ortho-phthalaldehyde derivative is stabilized at low temperature.
Williams LD; Meredith FI; Riley RT
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):311-4. PubMed ID: 15171945
[TBL] [Abstract][Full Text] [Related]
39. Dependence of the sphingoid bases concentration on growth phase and temperature in the yeast Yarrowia lipolytica.
Bauman M; Mesarić M; Ribar S; Marić V
J Basic Microbiol; 2002; 42(1):3-12. PubMed ID: 11925759
[TBL] [Abstract][Full Text] [Related]
40. 1,3,5,7-Tetramethyl-8-aminozide-difluoroboradiaza-s-indacene as a new fluorescent labeling reagent for the determination of aliphatic aldehydes in serum with high performance liquid chromatography.
Xiong XJ; Wang H; Rao WB; Guo XF; Zhang HS
J Chromatogr A; 2010 Jan; 1217(1):49-56. PubMed ID: 19942225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
